tailieunhanh - Phase I/II dose-finding study of nanoparticle albumin-bound paclitaxel (nab®-Paclitaxel) plus cisplatin as treatment for metastatic nasopharyngeal carcinoma

This phase I/II study aimed to determine the maximum tolerated dose (MTD) of nanoparticle albumin-bound paclitaxel (nab® -paclitaxel) plus cisplatin as treatment for metastatic nasopharyngeal carcinoma (NPC). |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN